We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

128 hedge funds and large institutions have $604M invested in Cardiovascular Systems, Inc. in 2018 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 48 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less funds holding

Funds holding: 134128 (-6)

7% less capital invested

Capital invested by funds: $649M → $604M (-$45.2M)

20% less call options, than puts

Call options by funds: $44K | Put options by funds: $55K

21% less repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 48

22% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 23

Holders
128
Holders Change
-6
Holders Change %
-4.48%
% of All Funds
2.93%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
38
Reduced
48
Closed
23
Calls
$44K
Puts
$55K
Net Calls
-$11K
Net Calls Change
-$137K
Name Holding Trade Value Shares
Change
Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$64.2M -$1.35M -56,363 -2%
BCM
2
Brown Capital Management
Maryland
$59.9M +$1.77M +73,581 +3%
CIP
3
Champlain Investment Partners
Vermont
$56.8M +$8.1M +336,975 +15%
BlackRock
4
BlackRock
New York
$49.8M +$89.2K +3,709 +0.2%
Vanguard Group
5
Vanguard Group
Pennsylvania
$33.3M -$8.25M -343,047 -18%
CCM
6
Camber Capital Management
Massachusetts
$27.1M +$29.7M +1,236,360 New
Renaissance Technologies
7
Renaissance Technologies
New York
$19.7M +$16.8K +700 +0.1%
CAM
8
Cortina Asset Management
Wisconsin
$18.4M +$1.61M +66,768 +9%
PHS
9
PFM Health Sciences
California
$18M +$6.53M +271,497 +49%
FCM
10
Frontier Capital Management
Massachusetts
$17.3M -$83.3K -3,467 -0.4%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$16.7M -$4.41M -183,421 -19%
State Street
12
State Street
Massachusetts
$16.7M -$5.24M -217,932 -22%
Deutsche Bank
13
Deutsche Bank
Germany
$15.8M +$3.91M +162,519 +29%
New York State Common Retirement Fund
14
New York State Common Retirement Fund
New York
$11.8M -$357K -14,837 -3%
FLAM
15
First Light Asset Management
Minnesota
$10.3M +$617K +25,683 +6%
Point72 Asset Management
16
Point72 Asset Management
Connecticut
$9.81M +$1.93M +80,300 +22%
CCM
17
Consonance Capital Management
New York
$9.78M +$10.7M +446,100 New
Norges Bank
18
Norges Bank
Norway
$9.75M -$3.06M -127,175 -22%
Northern Trust
19
Northern Trust
Illinois
$9.32M -$229K -9,530 -2%
First Manhattan
20
First Manhattan
New York
$9.21M
MWNA
21
Marshall Wace North America
New York
$7.12M -$5.61M -233,511 -42%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$6.88M +$364K +15,150 +5%
GIM
23
Granahan Investment Management
Massachusetts
$6.34M +$530K +22,056 +8%
GF
24
Gabelli Funds
New York
$5.26M +$48.1K +2,000 +0.8%
Morgan Stanley
25
Morgan Stanley
New York
$4.18M +$764K +31,786 +20%

CSII Hedge Fund Activity: Q1 2018 in Review

128 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q1 2018, worth a combined $604M — down 7% from $649M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of CSII and 18 opened new positions — a net loss of 5 holders — while 48 trimmed existing stakes and 38 added.

The largest buyer was Camber Capital Management, opening a new position worth an estimated $29.7M. The largest seller was Redwood Investments, exiting entirely with an estimated $11.2M sold.

  • 128 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q1 2018, down from 134 in Q4 2017.
  • Funds reported $604M of Cardiovascular Systems, Inc. stock for Q1 2018, down 7% quarter-over-quarter.
  • 18 funds opened new Cardiovascular Systems, Inc. positions in Q1 2018 and 23 closed out, a net change of -5 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q1 2018 was Camber Capital Management, an estimated $29.7M added.
  • The largest Cardiovascular Systems, Inc. seller in Q1 2018 was Redwood Investments, an estimated $11.2M sold.

Based on aggregated 13F filings for Q1 2018.